Advertisement
Advertisement

JSPR

JSPR logo

Jasper Therapeutics Inc

22.18
USD
-0.27
-1.20%
Dec 18, 13:24 UTC -5
Open

Jasper Therapeutics Inc Profile

About

Jasper Therapeutics Inc., a biotechnology company focused on hematopoietic cell transplant therapies. Jasper Therapeutics Inc., formerly known as Amplitude Healthcare Acquisition Corporation, is based in REDWOOD CITY, Calif.

Info & Links

CEO

Ronald Martell

Headquarters

2200 BRIDGE PKWY SUITE #102
REDWOOD CITY, CA 94065, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

15

Employees

45

Jasper Therapeutics Inc Statistics

Valuation Measures

Market Capitalization2

332.70M

Enterprise Value

240.20M

Enterprise Value/EBITDA(ttm)

-3.57

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

3.69

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-67.64%

Return on Invested Capital(ttm)

-70.07%

Return on Assets(ttm)

-58.53%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-67.27M

Net Income Available to Common(ttm)

-63.53M

Diluted EPS(ttm)

-4.74

Share Statistics

Beta (5Y Monthly)

2.18

52-Week Change

269.91%

S&P 500 52-Week Change

27.86%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

15.00M

Dividend Yield

0.00%

Float4

14.60M

% Held by Insiders

2.70%

% Held by Institutions

79.85%

Balance Sheet

Total Cash(mrq)

92.50M

Total Cash Per Share(mrq)

6.17

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

7.61%

Quick Ratio(mrq)

7.61%

Book Value Per Share(mrq)

5.58

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.76

Free Cash Flow(ytd)

-41.92M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement